HuGE Literature Finder
Records
1
-
8
Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia. Cancer reports (Hoboken, N.J.) 2022 11 e1744. Yunis Luz K, Linares-Ballesteros Adriana, Aponte Nelson, Barros Gisela, García Johnny, Niño Laura, Uribe Gloria, Quintero Edna, Yunis Juan |
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). ESMO open 2020 Dec 6 (1): 100019. Pellegrino B, Cavanna L, Boggiani D, Zamagni C, Frassoldati A, Schirone A, Caldara A, Rocca A, Gori S, Piacentini F, Berardi R, Brandes A A, Foglietta J, Villa F, Todeschini R, Tognetto M, Naldi N, Bortesi B, Montemurro F, Ardizzoni A, Boni L, Musolino |
An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance).
![]() Pharmacogenetics and genomics 2019 Mar . Innocenti Federico, Jiang Chen, Sibley Alexander B, Denning Stefanie, Etheridge Amy S, Watson Dorothy, Niedzwiecki Donna, Hatch Ace J, Hurwitz Herbert I, Nixon Andrew B, Furukawa Yoichi, Kubo Michiaki, Crona Daniel J, Kindler Hedy L, McLeod Howard L, Ratain Mark J, Owzar Kour |
sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-a therapy. Annals of hematology 2017 Feb . Jud Stéphanie, Goede Jeroen S, Senn Oliver, Spanaus Katharina, Manz Markus G, Benz Rudo |
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment. Leukemia & lymphoma 2017 12 58 (12): 2880-2894. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Martínez-Cuadrón David, Rojas Luis, Rodríguez-Veiga Rebeca, Boluda Blanca, Sendra Luis, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLoS medicine 2017 9 14 (9): e1002382. Molokie Robert, Lavelle Donald, Gowhari Michel, Pacini Michael, Krauz Lani, Hassan Johara, Ibanez Vinzon, Ruiz Maria A, Ng Kwok Peng, Woost Philip, Radivoyevitch Tomas, Pacelli Daisy, Fada Sherry, Rump Matthew, Hsieh Matthew, Tisdale John F, Jacobberger James, Phelps Mitch, Engel James Douglas, Saraf Santhosh, Hsu Lewis L, Gordeuk Victor, DeSimone Joseph, Saunthararajah Yog |
Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid Leukemia. BioMed research international 2015 2015 309491. Medina-Sanson Aurora, Ramírez-Pacheco Arturo, Moreno-Guerrero Silvia Selene, Dorantes-Acosta Elisa María, Sánchez-Preza Metzeri, Reyes-López Alfon |
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Mar 23 (3): 670-7. Tibaldi C, Giovannetti E, Tiseo M, Leon L G, D'Incecco A, Loosekoot N, Bartolotti M, Honeywell R, Cappuzzo F, Ardizzoni A, Peters G |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: